Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Total Liabilities : ¥795 Mil (As of Dec. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Tibet Rhodiola Pharmaceutical Holding Co Total Liabilities?

Tibet Rhodiola Pharmaceutical Holding Co's Total Liabilities for the quarter that ended in Dec. 2024 was ¥795 Mil.

Tibet Rhodiola Pharmaceutical Holding Co's quarterly Total Liabilities declined from Jun. 2024 (¥1,510.61 Mil) to Sep. 2024 (¥1,007.31 Mil) and declined from Sep. 2024 (¥1,007.31 Mil) to Dec. 2024 (¥795.23 Mil).

Tibet Rhodiola Pharmaceutical Holding Co's annual Total Liabilities increased from Dec. 2022 (¥1,068.89 Mil) to Dec. 2023 (¥1,213.74 Mil) but then declined from Dec. 2023 (¥1,213.74 Mil) to Dec. 2024 (¥795.23 Mil).

Tibet Rhodiola Pharmaceutical Holding Co Total Liabilities Historical Data

The historical data trend for Tibet Rhodiola Pharmaceutical Holding Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Rhodiola Pharmaceutical Holding Co Total Liabilities Chart

Tibet Rhodiola Pharmaceutical Holding Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

359.09

1,157.64

1,068.89

1,213.74

795.23

Tibet Rhodiola Pharmaceutical Holding Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															1,213.74	1,397.35	1,510.61	1,007.31	795.23

Tibet Rhodiola Pharmaceutical Holding Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tibet Rhodiola Pharmaceutical Holding Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	766.571	+	(0.302	+	28.36
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	795

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	4747.338	-	3952.105
	=	795

Tibet Rhodiola Pharmaceutical Holding Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	766.571	+	(0.302	+	28.36
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	795

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	4747.338	-	3952.105
	=	795

Tibet Rhodiola Pharmaceutical Holding Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Tibet Rhodiola Pharmaceutical Holding Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Tibet Rhodiola Pharmaceutical Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 93, Beijing Middle Road, Tibet Autonomous Region, Lhasa, CHN, 610023

Website

http://www.xzyy.cn

Tibet Rhodiola Pharmaceutical Holding Co is a Chinese company producing biological products and traditional Tibetan medicines.

Executives

Wang Bao Ming	senior management
Peng Hui	Director
Cao Shu Zhen	senior management
Si Qin	Director
Ren Bei Chen	Supervisors
Liu De Gong	Supervisors
Gao Zi Li	senior management
Zhou Ming De	senior management
Chen Li Ye	senior management
Lin Ben	Director
Chen Da Bin	Director

Tibet Rhodiola Pharmaceutical Holding Co Headlines

No Headlines